COV
CLEO DIAGN FPO [COV]
Healthcare · ASX Small Cap
$0.3450 -2.8%
Updated 22 Jul 2026 · Signals refresh every scan
Get alerts when COV triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI is looking oversold — historically a spot where stocks tend to bounce
- MACD momentum is losing steam
- Stochastic is deep in oversold territory — bounce conditions forming
- Volume surging at 5.2x normal while price falls — heavy selling pressure
- Sitting near support — this level has held before and could attract buyers again
- Took a hit — down 14.8% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.73, underperforming its peers
- Strong cash runway (15 quarters)
- Strong revenue growth (+373%)
- Near 52-week low (6% of range)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 34% over the past year
- Revenue growing at +373% — the top line is moving in the right direction
- Altman Z-Score grey zone (1.91, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-157%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-1.98%/day)
Ask Scout AI about COV
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE CLEO Enters Analytical Validation Phase
NONE Change in Director's Interest Notice
NONE Cleansing Notice
Recent ASX Announcements
| 2026-07-12 | CLEO Enters Analytical Validation Phase PRICE SENSITIVE |
| 2026-07-07 | Change in Director's Interest Notice |
| 2026-05-28 | Cleansing Notice |
| 2026-05-28 | Application for quotation of securities - COV |
Key Metrics
$50.7M
Market Cap
258K
Avg Volume
5.2x
Vol Ratio
$0.34 — $0.90
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-49.6%
ROE
-157.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 61% |
| L | Leader vs Laggard | laggard | RS: -22 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
101 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track COV and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required